20 mg · vegan · gluten-free · 60 caps
Affiliate link · we earn from qualifying purchases. No paid placements.
Pyrroloquinoline quinone (PQQ) is a redox cofactor and antioxidant compound originally discovered in bacteria. It is found in trace amounts in fermented soybeans, spinach, green tea and human breast milk. As a supplement, it is one of the only known compounds that stimulates the growth of entirely new mitochondria (mitochondrial biogenesis).
PQQ activates the SIRT1/PGC-1α signalling pathway — the master genetic switch that tells cells to build more mitochondria and upgrade existing ones. It also scavenges superoxide radicals directly within the mitochondrial matrix, protecting the very organelles it helps create. In skeletal muscle, this translates to more ATP-producing factories and improved oxygen utilisation.
Individuals with age-related fatigue, metabolic syndrome, cognitive decline, poor exercise recovery and anyone seeking long-term mitochondrial renewal. Particularly valuable for those whose fatigue stems from insufficient mitochondrial number rather than temporary nutrient deficiency.
Pregnant or breastfeeding women due to limited safety data. Those with existing insomnia may prefer morning-only dosing. Side effects: Very well tolerated. Rare mild headaches, insomnia or appetite changes at 20 mg. No serious adverse events in human trials up to 60 mg/day.
A plain-English read of the literature behind this supplement. Not a clinical recommendation.
Key citations: PMID 31860387 (Hwang et al. — Effects of PQQ on aerobic exercise performance and mitochondrial biogenesis in untrained men, J Am Coll Nutr 2020), PMID 41503358 (Zhang et al. — No effect of PQQ on body weight but increase in mitochondrial biogenesis, Metabol Open 2025), PMID 31860387 (PGC-1α protein significantly elevated in PQQ group vs placebo after 6 weeks)
SacredBod's longer take on PQQ Mitochondrial Biogenesis — context the structured blocks above don't capture.
Pyrroloquinoline quinone sounds like a laboratory accident, but it is a naturally occurring redox cofactor that bacteria have used for billions of years to catalyse energy reactions. Humans obtain trace amounts from fermented foods, tea and spinach, but dietary intake is far below the doses shown to trigger mitochondrial biogenesis.
What makes PQQ unique is that it does not merely protect existing mitochondria or feed them fuel — it actually signals the cell to manufacture new ones. Through the SIRT1/PGC-1α pathway, PQQ turns on the genetic programme for mitochondrial replication, effectively upgrading your cellular power plants from the inside out.
In India, PQQ is emerging as a premium nootropic and anti-ageing supplement, often marketed alongside CoQ10 as a “mitochondrial stack.”
PQQ operates through three verified mechanisms:
PQQ has an outstanding safety profile. Toxicology studies in animals showed no adverse effects at doses hundreds of times higher than the human equivalent. Human trials up to 60 mg/day reported only occasional headaches or insomnia, easily resolved by morning dosing. No drug interactions are known, though theoretical synergy exists with metformin and exercise.
Sanskrit/Hindi name: Not applicable — modern mitochondrial cofactor.
Availability: PQQ 20 mg is now readily available on Amazon.in from multiple brands:
Prices range from ₹800–₹1,500 for one-month supplies. It is not a Schedule H drug and requires no prescription.
Ayurvedic parallel: Amalaki (Indian gooseberry) is the classical “Rasayana” par excellence, and modern research shows it protects mitochondrial membranes from oxidative damage. PQQ can be viewed as a targeted, high-potency mitochondrial Rasayana that complements Amalaki’s broader antioxidant profile.
Traditional use: None in Charaka or Sushruta Samhitas — this is a 21st-century mitochondrial biogenesis agent.
Peptides are physician-only. Tell us a bit and we'll route you to the right specialist.
